tiprankstipranks
Protalix Biotherapeutics (PLX)
:PLX
US Market

Protalix (PLX) Income Statement

Compare
766 Followers

Protalix Income Statement

Last quarter (Q3 2024), Protalix's total revenue was $17.96M, an increase of 73.60% from the same quarter last year. In Q3, Protalix's net income was $3.24M. See Protalix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 65.49M$ 47.64M$ 38.35M$ 62.90M$ 54.69M
Gross Profit
$ 42.51M$ 28.05M$ 22.00M$ 52.02M$ 43.80M
Operating Expenses
$ 32.05M$ 41.06M$ 42.46M$ 49.31M$ 54.52M
Depreciation and Amortization
$ 1.19M$ 1.09M$ 1.12M$ 1.30M$ 1.62M
EBITDA
$ 11.65M$ -10.78M$ -18.94M$ 4.45M$ -8.69M
Operating Income
$ 10.46M$ -13.01M$ -20.46M$ 1.85M$ -10.72M
Other Income/Expenses
$ -1.89M$ -1.38M$ -7.12M$ -9.23M$ -7.56M
Pretax Income
$ 8.57M$ -14.40M$ -27.58M$ -6.52M$ -18.28M
Net Income
$ 8.31M$ -14.93M$ -33.98M$ -14.89M$ -26.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.12$ -0.31$ -0.77$ -0.51$ -1.77
Diluted EPS
$ 0.10$ -0.31$ -0.77$ -0.51$ -1.77
Weighted Average Shares Outstanding
67.51M 48.47M 44.14M 29.15M 14.84M
Weighted Average Shares Outstanding (Diluted)
82.42M 48.47M 44.14M 29.15M 14.84M
Currency in USD

Protalix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis